Centessa Pharmaceuticals (NASDAQ:CNTA) just reported results for the fourth quarter of 2023.
- Centessa Pharmaceuticals reported earnings per share of -38 cents. This was above the analyst estimate for EPS of -48 cents.
- The company reported revenue of $6.85 million.